Although codeine-ibuprofen can be considered a relatively weak opioid analgesic, it is nevertheless addictive.

Twenty seven patients with serious morbidity were studied. On average, the patients were taking daily doses of 435-602mg of codeine phosphate and 6800-9400mg ibuprofen.
Dr Frei said that the patients suffered from gastrointestinal disease, renal failure and anaemia and that most patients had no previous history of substance-use disorder.
“In many of these cases, serious morbidity resulted from use initiated for therapeutic reasons, such as easing persisting pain,” Dr Frei said.
“Given that these drugs are likely to remain available without prescription in Australia, physicians should ask specifically about non-prescribed analgesics when taking a medication history.
“Pharmacy personnel should consider the risk of misuse when supplying these combination analgesic products.
Advertisement
The Medical Journal of Australia is a publication of the Australian Medical Association.
Advertisement